RAPP Rapport Therapeutics, Inc.

NEUTRAL Impact: 3/10 Institutional Cluster
Horizon weeks Processed 2d 4h ago
Institutional cluster: 3 buyers, 0 sellers (bullish)

Executive Summary

Three mega-passive institutional investors (Vanguard, BlackRock, Fidelity) collectively added $211.6M to their RAPP positions during Q3 2025, increasing holdings by 26-47%. This is a routine index-fund rebalancing signal, not an active investment thesis, and the stock has historically underperformed following prior reports on this ticker.

Key Financial Metrics

Direction
accumulating
Buy Value
$300.3M
Net Flow
$211.6M

Institutional Positions

Net institutional flow: $211.6M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Vanguard ADD +46.9% $48.3M $35.7M
BlackRock ADD +28.6% $46.6M $32.7M
Fidelity ADD +26.3% $205.4M $143.2M

Actionable Insight

This cluster is dominated by passive index-fund rebalancing, not active conviction. The historical performance on RAPP reports shows a 0% win rate at T+20 with average alpha of -7.79% vs SPY. The stock has been a consistent underperformer. Do not read this as a bullish signal — monitor for actual active manager accumulation or fundamental catalysts before acting.

Key Facts

  • 3 passive/index fund managers added $211.6M net to RAPP positions in Q3 2025
  • Fidelity was the largest buyer, adding $143.2M (26.3% share increase)
  • Vanguard added $35.7M (46.9% share increase), BlackRock added $32.7M (28.6% increase)
  • No institutional sellers were identified in this cluster
  • All three buyers are mega-passive managers, not active hedge funds or activists

Financial Impact

3 institutions accumulated $211.6M in new RAPP positions during Q3 2025, with total holdings reaching $300.3M

institutional ownershipfloat

Risk Factors

  • Passive fund flows are mechanical, not thesis-driven — may reverse on next rebalance
  • Historical RAPP reports show persistent negative alpha following our analysis
  • No active managers or hedge funds participated in this cluster, reducing signal quality
  • 13F data is 45+ days stale; positions may have already been adjusted

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-RAPP-2025-Q3
11 reports for RAPP
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +24.87%Mar 10, 2026
Filters
Rows
Reports for RAPP — sortable, filterable
Type Now
Jun 11, 2026
2d ago
Institutional Cluster
NEUTRAL ★ 3/10
$35.19 awaiting T+5awaiting T+5
May 27, 2026
17d ago
144
BEARISH ★ 5/10
$39.51 $34.90▲ +11.67%▲ +12.88%
May 11, 2026
4w ago
144
BEARISH ★ 5/10
$37.24 $35.18▲ +5.53%▲ +5.61%
May 8, 2026
5w ago
144
NEUTRAL ★ 3/10
$38.43 $35.18▼ −8.46%▼ −8.37%
May 7, 2026
5w ago
144
NEUTRAL ★ 3/10
$38.04 $37.95▼ −0.24%▼ −1.70%
May 7, 2026
5w ago
8-K
MIXED ★ 6/10
$39.93 $38.08▼ −4.63%▼ −6.14%
Apr 23, 2026
7w ago
DEFA14A
NEUTRAL ★ 2/10
$36.36 $33.00▼ −9.24%▼ −10.72%
Apr 21, 2026
7w ago
Press Release
BULLISH ★ 8/10
$36.78 $33.30▼ −9.48%▼ −9.53%
Apr 1, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$31.67 $34.22▲ +8.05%▲ +4.29%
Mar 30, 2026
10w ago
144
NEUTRAL ★ 3/10
$31.29 $33.69▲ +7.67%▲ +3.73%
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (47h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access